Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. We show 10 historical shares outstanding datapoints in our EVGN shares outstanding history coverage, used to compute EVGN market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing EVGN market cap history over the course of time is important for investors
interested in comparing EVGN's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of EVGN versus a peer is one thing; comparing
EVGN market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like EVGN can fluctuate over the course of history.
With this page we aim to empower investors researching EVGN by allowing them to research the EVGN market cap history. |
Free EVGN Email Alerts:
Video: The Importance of Market Cap
